ArticleInternal medicine (Tokyo, Japan)2022

Dermatomyositis Which Was Double Positive for Anti-MDA5 and Anti-ARS Antibodies That Was Successfully Treated by Intensive Immunosuppressive Therapy.

Satoshi Hama et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.